Literature DB >> 2947039

Prolonged exercise causes an increase in the activity of galactosylhydroxylysyl glucosyltransferase and in the concentration of type III procollagen aminopropeptide in human serum.

T E Takala, J Vuori, H Anttinen, K Väänänen, R Myllylä.   

Abstract

The effect of prolonged heavy physical exercise on serum galactosylhydroxylysyl glucosyltransferase activity (S-GGT) and serum type III procollagen aminoterminal propeptide (S-Pro(III)-N-P) concentration was studied in healthy male long-distance runners. S-GGT increased gradually by about 70% (p less than 0.01) during a competitive 24-h run, and a rising trend was also observed in S-Pro(III)-N-P. After the termination of the run S-GGT was normalized in two days, but the increase in S-Pro(III)-N-P continued up to one day after the race, reaching nearly 40% (p less than 0.005). The alterations in S-GGT and S-Pro(III)-N-P showed no significant correlation with S-CK, S-LDH or the distance run. The most likely explanation for the increases in S-GGT and S-Pro(III)-N-P is that prolonged heavy exercise injures the collagen-synthesizing cells of the connective tissue, leading to a short-term increase in type III procollagen production.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2947039     DOI: 10.1007/bf00657507

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  25 in total

1.  Enzymes of collagen biosynthesis in skin and serum and dermatological diseases. II. Serum enzymes.

Authors:  E R Kuutti-Savolainen
Journal:  Clin Chim Acta       Date:  1979-08-15       Impact factor: 3.786

Review 2.  Collagen glycosyltransferases.

Authors:  K I Kivirikko; R Myllylä
Journal:  Int Rev Connect Tissue Res       Date:  1979

3.  Studies on the collagen glucosyltransferase activity present in platelets and plasma.

Authors:  S Menashi; M E Grant
Journal:  Biochem J       Date:  1979-03-15       Impact factor: 3.857

4.  The biosynthesis of collagen and its disorders (first of two parts).

Authors:  D J Prockop; K I Kivirikko; L Tuderman; N A Guzman
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

5.  Changes in collagen metabolism in diseased muscle. I. Biochemical studies.

Authors:  R Myllylä; V V Myllylä; U Tolonen; K I Kivirikko
Journal:  Arch Neurol       Date:  1982-12

6.  Evidence of impaired left ventricular performance after an uninterrupted competitive 24 hour run.

Authors:  K O Niemelä; I J Palatsi; M J Ikäheimo; J T Takkunen; J J Vuori
Journal:  Circulation       Date:  1984-09       Impact factor: 29.690

7.  Enzymes of collagen synthesis and type III procollagen aminopropeptide in the evaluation of D-penicillamine and medroxyprogesterone treatments of primary biliary cirrhosis.

Authors:  E R Savolainen; T A Miettinen; P Pikkarainen; M P Salaspuro; K I Kivirikko
Journal:  Gut       Date:  1983-02       Impact factor: 23.059

8.  Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease.

Authors:  E R Savolainen; B Goldberg; M A Leo; M Velez; C S Lieber
Journal:  Alcohol Clin Exp Res       Date:  1984 Jul-Aug       Impact factor: 3.455

9.  Serum and urine analysis of the aminoterminal procollagen peptide type III by radioimmunoassay with antibody Fab fragments.

Authors:  H Rohde; I Langer; T Krieg; R Timpl
Journal:  Coll Relat Res       Date:  1983-09

10.  Enzymes of collagen synthesis and type III procollagen amino-propeptide in serum from Nigerians with hepato-cellular carcinoma and other malignant diseases.

Authors:  D M Bolarin; E R Savolainen; K I Kivirikko
Journal:  Int J Cancer       Date:  1982-04-15       Impact factor: 7.396

View more
  1 in total

1.  Evaluation of early biomarkers of muscle anabolic response to testosterone.

Authors:  Fabian Chen; Raymond Lam; David Shaywitz; Ronald C Hendrickson; Gregory J Opiteck; Dana Wishengrad; Andy Liaw; Qinghua Song; Adrian J Stewart; Corinne E Cummings; Chan Beals; Kevin E Yarasheski; Alise Reicin; Marcella Ruddy; Xuguang Hu; Nathan A Yates; Joseph Menetski; Gary A Herman
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-02-26       Impact factor: 12.910

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.